Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9BU6

Vaccine elicited Fab C968.180 with influenza H10 JD13 HA trimer

Summary for 9BU6
Entry DOI10.2210/pdb9bu6/pdb
EMDB information44901
DescriptorFab C968.180 heavy chain, Fab C968.180 light chain, Hemagglutinin HA1, ... (7 entities in total)
Functional Keywordsvaccine, viral protein-immune system complex, immune system, viral protein/immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains12
Total formula weight269927.82
Authors
Gorman, J.,Kwong, P.D. (deposition date: 2024-05-16, release date: 2024-11-27, Last modification date: 2025-01-22)
Primary citationMantus, G.E.,Chopde, A.J.,Gorman, J.,Cominsky, L.Y.,Ourahmane, A.,Creanga, A.,Shimberg, G.D.,Gillespie, R.A.,Van Wazer, D.J.,Zhou, T.,Gajjala, S.R.,Williams, C.,Maestle, E.,Reed, D.S.,Serebryannyy, L.,Costner, P.,Holman, L.,Casazza, J.P.,Koup, R.A.,Dropulic, L.K.,Kwong, P.D.,McDermott, A.B.,Kanekiyo, M.,Andrews, S.F.
Vaccination with different group 2 influenza subtypes alters epitope targeting and breadth of hemagglutinin stem-specific human B cells.
Sci Transl Med, 17:eadr8373-eadr8373, 2025
Cited by
PubMed Abstract: The conserved influenza hemagglutinin stem, which is a target of cross-neutralizing antibodies, is now used in vaccine strategies focused on protecting against influenza pandemics. Antibody responses to group 1 stem have been extensively characterized, but little is known about group 2. Here, we characterized the stem-specific repertoire of individuals vaccinated with one of three group 2 influenza subtypes (H3, H7, or H10). Epitope mapping revealed two epitope supersites on the group 2 stem. Antibodies targeting the central epitope were broadly cross-reactive, whereas antibodies targeting the lower epitope had narrower breadth but higher potency against H3 subtypes. The ratio of B cells targeting each of the supersites varied with the vaccine subtype, leading to differences in the cross-reactivity of the B cell response. Our findings suggest that vaccine strategies targeting both group 2 stem epitopes would be complementary, eliciting broader and more potent protection against both seasonal and pandemic influenza strains.
PubMed: 39742506
DOI: 10.1126/scitranslmed.adr8373
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.65 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon